Malignant Urethral Neoplasm
1 clinical trials · Condition
◉ Watch Malignant Urethral Neoplasm
| Record | Firm | Date |
|---|---|---|
| Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology (NCT05756569) | Emory University | 2023-09-26 |
Track Malignant Urethral Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.